23 results on '"Finocchietto, P."'
Search Results
2. Inhibition of Mitochondrial Fission by Drp-1 Blockade by Short-Term Leptin and Mdvi-1 Treatment Improves White Adipose Tissue Abnormalities in Obesity and Diabetes
- Author
-
Finocchietto, P, primary, Perez, H, additional, Blanco, G, additional, Miksztowicz, V, additional, Marotte, C, additional, Morales, C, additional, Peralta, J, additional, Berg, G, additional, Poderoso, C, additional, Poderoso, JJ, additional, and Carreras, MC, additional
- Published
- 2021
- Full Text
- View/download PDF
3. MITOCHONDRIAL TRANSLOCATION OF INDUCIBLE NITRIC OXIDE SYNTHASE AS A MECHANISM OF MITOCHONDRIAL NITROSATIVE DAMAGE IN ENDOTOXEMIA: S1-7
- Author
-
Carreras, M. C., Antico Arciuch, V. G., Franco, M. C., Finocchietto, P., Peralta, J. G., and Poderoso, J. J.
- Published
- 2004
4. ANÁLISIS DE LOS PRIMEROS 100 PACIENTES INTERNADOS POR COVID-19 EN EL HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN, UNIVERSIDAD DE BUENOS AIRES.
- Author
-
GUILLERMINA LUDUEÑA, MARÍA, LABATO, MARIANA, CHIARADIA, VERÓNICA, YAMUNI, JUAN, FINOCCHIETTO, PAOLA, and PISAREVSKY, ANA A.
- Abstract
Copyright of Medicina (Buenos Aires) is the property of Medicina (Buenos Aires) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2020
5. Finocchietto, P
- Author
-
Finocchietto, P and Finocchietto, P
- Published
- 2018
6. Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB
- Author
-
Engelbrechtsen, Line, Lundgren, J, Wewer Albrechtsen, Nicolai Jacob, Mahendran, Yuvaraj, Iepsen, Eva Pers Winning, Finocchietto, P., Jonsson, Anna Elisabet, Madsbad, Sten, Holst, Jens Juul, Vestergaard, Henrik, Hansen, T., and Torekov, Signe Sørensen
- Subjects
Journal Article ,lipids (amino acids, peptides, and proteins) - Abstract
Background: Dislipidaemia and increased levels of apolipoprotein B (apoB) in individuals with obesity are risk factors for development of cardiovascular disease (CVD). The aim of this study was to investigate the effect of weight loss and weight maintenance with and without liraglutide treatment on plasma lipid profiles and apoB.Methods: Fifty-eight individuals with obesity (body mass index 34.5 ± 3.0 kg/m2 [mean ± SD]) were included in this study. After 8 weeks on a very low-calorie diet (800 kcal/day), participants were randomized to weight maintenance with meal replacements with or without liraglutide (1.2 mg daily) for 1 year. Plasma samples from before and after weight loss and after 1 year of weight maintenance were subjected to nuclear magnetic resonance-based lipidomics analysis.Results: After an 8-week low-calorie diet, study participants lost 12.0 ± 2.9 kg (mean ± SD) of their body weight, which was reflected in their lipid profiles (80 out of 124 lipids changed significantly), including reduced levels of apoB, total cholesterol, free cholesterol, remnant cholesterol, triglycerides, low-density lipoprotein and very low-density lipoprotein subclasses. After 1 year of maintained weight loss, the majority of the lipids had returned to pre-weight loss levels even though weight loss was successfully maintained in both groups. Interestingly, apoB levels remained low in the liraglutide treated group (apoB change: 0.03 ± 0.02 mmol/L, p = 0.4) in contrast to an increase in the control group (apoB change: 0.06 ± 0.07 mmol/L, p = 0.02).Conclusion: An 8-week low-calorie diet, in individuals with obesity, reduced plasma levels of lipids and the atherogenic marker apoB. After 1 year of weight maintenance, only study participants treated with liraglutide maintained reduced levels of apoB, despite similar body weight maintenance. Treatment with liraglutide may therefore reduce apoB levels and thus reflect lower CVD risk. Including apoB measurements in clinical practice when monitoring patients with dislipidemia or CVD might prove to be useful.
- Published
- 2017
- Full Text
- View/download PDF
7. TYPE 1 DIABETES AND SUBCUTANEOUS INSULIN RESISTANCE SYNDROME TREATED WITH PANCREAS TRANSPLANTATION.
- Author
-
RUEDA, DARÍO A., REISSIG, FEDERICO, LEANZA, MATÍAS, AGUIRRE, RAFAEL, CONTARDO, DAMIÁN, HERNÁNDEZ, SILVIA, DI FONZO, HORACIO, and FINOCCHIETTO, PAOLA
- Abstract
Copyright of Medicina (Buenos Aires) is the property of Medicina (Buenos Aires) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
8. Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB
- Author
-
Engelbrechtsen, L., primary, Lundgren, J., additional, Wewer Albrechtsen, N. J., additional, Mahendran, Y., additional, Iepsen, E. W., additional, Finocchietto, P., additional, Jonsson, A. E., additional, Madsbad, S., additional, Holst, J. J., additional, Vestergaard, H., additional, Hansen, T., additional, and Torekov, S. S., additional
- Published
- 2017
- Full Text
- View/download PDF
9. Liraglutide improves adipose tissue remodeling and mitochondrial dynamics in a visceral obesity model induced by a high-fat diet.
- Author
-
Vanessa, Touceda, Florencia, Fontana Estevez, Leonardo, Cacciagiú, Paola, Finocchietto, Romina, Bustos, Agustina, Vidal, Gabriela, Berg, Celina, Morales, Germán, González, and Miksztowicz, Veronica
- Abstract
Central obesity is characterized by visceral adipose tissue (VAT) expansion, considered one of the main risk factors for metabolic complications. In recent years, new drugs have been studied for obesity treatment. Liraglutide (LGT), a GLP-1 agonist, decreases body weight, however, several mechanisms of action on VAT are still unknown. Aim: to study the effect of LGT on factors associated with VAT remodeling and mitochondrial dynamics in mice fed a high-fat diet (HFD). Methods: C57BL/6 mice were divided into Control (C) and HFD. After 15 weeks of feeding, each group was subdivided according to LGT administration for 5 weeks: C, C+ LGT, HFD, and HFD+LGT. In epididymal AT (EAT) we evaluated histological and mitochondrial characteristics, vascularity, gelatinase activity (MMPs), and galectin-3 expression. Results: HFD presented larger adipocytes (p<0.05), and lower vascular density and MMP-9 activity (p<0.01) than C, while a major number of smaller adipocytes (p<0.05) and an increase in vascularity (p<0.001) and MMP-9 activity (p<0.01) was observed in HFD+LGT. Collagen content was higher (p<0.05) in EAT from HFD and decreased in HFD+LGT. In C, C+LGT, and HFD+LGT, mitochondria were predominantly tubular-shaped while in HFD mitochondria were mostly spherical (p<0.001). Conclusion: LGT positively influences VAT behavior by modulating gelatinase activity, enhancing vascularization, and improving adipocyte histological characteristics. Additionally, LGT improves mitochondrial dynamics, a process that would favor VAT functionality.
- Published
- 2024
- Full Text
- View/download PDF
10. Abnormal mitochondrial fusion–fission balance contributes to the progression of experimental sepsis
- Author
-
Gonzalez, A. S., primary, Elguero, M. E., additional, Finocchietto, P., additional, Holod, S., additional, Romorini, L., additional, Miriuka, S. G., additional, Peralta, J. G., additional, Poderoso, J. J., additional, and Carreras, M. C., additional
- Published
- 2014
- Full Text
- View/download PDF
11. Angiotensin II Regulates Mitochondrial mTOR Pathway Activity Dependent on Acyl-CoA Synthetase 4 in Adrenocortical Cells
- Author
-
Helfenberger, Katia E, Argentino, Giuliana F, Benzo, Yanina, Herrera, Lucía M, Finocchietto, Paola, and Poderoso, Cecilia
- Abstract
Two well-known protein complexes in mammalian cells, mTOR type 1 and type 2 (mTORC1/2) are involved in several cellular processes such as protein synthesis, cell proliferation, and commonly dysregulated in cancer. An acyl-CoA synthetase type 4 (ACSL4) is one of the most recently mTORC1/2 regulators described, in breast cancer cells. The expression of ACSL4 is hormone-regulated in adrenocortical cells and required for steroid biosynthesis. mTORC1/2 have been reported to be crucial in the proliferation of human adrenocortical tumor cells H295R and interestingly reported at several subcellular locations, which has brought cell biology to the vanguard of the mTOR signaling field. In the present work, we study the regulation of mTORC1/2 activation by angiotensin II (Ang II)—the trophic hormone for adrenocortical cells—the subcellular localization of mTORC1/2 signaling proteins and the role of ACSL4 in the regulation of this pathway, in H295R cells. Ang II promotes activation by phosphorylation of mTORC1/2 pathway proteins in a time-dependent manner. Mitochondrial pools of ribosomal protein S6, protein kinase B (Akt) in threonine 308, and serine 473 and Rictor are phosphorylated and activated. Glycogen synthase kinase type 3 (GSK3) is phosphorylated and inactivated in mitochondria, favoring mTORC1 activation. Epidermal growth factor, a classic mTORC1/2 activator, promoted unique activation kinetics of mTORC1/2 pathway, except for Akt phosphorylation. Here, we demonstrate that ACSL4 is necessary for mTORC1/2 effectors phosphorylation and H295R proliferation, triggered by Ang II. Ang II promotes activation of mitochondrial mTORC1/2 signaling proteins, through ACSL4, with a direct effect on adrenocortical cellular proliferation.
- Published
- 2022
- Full Text
- View/download PDF
12. Liraglutide improves adipose tissue remodeling and mitochondrial dynamics in a visceral obesity model induced by a high-fat diet.
- Author
-
Touceda V, Fontana Estevez F, Cacciagiú L, Finocchietto P, Bustos R, Vidal A, Berg G, Morales C, González G, and Miksztowicz V
- Abstract
Central obesity is characterized by visceral adipose tissue (VAT) expansion, considered one of the main risk factors for metabolic complications. In recent years, new drugs have been studied for obesity treatment. Liraglutide (LGT), a GLP-1 agonist, decreases body weight, however, several mechanisms of action on VAT are still unknown., Aim: to study the effect of LGT on factors associated with VAT remodeling and mitochondrial dynamics in mice fed a high-fat diet (HFD)., Methods: C57BL/6 mice were divided into Control (C) and HFD. After 15 weeks of feeding, each group was subdivided according to LGT administration for 5 weeks: C, C + LGT, HFD, and HFD + LGT. In epididymal AT (EAT) we evaluated histological and mitochondrial characteristics, vascularity, gelatinase activity (MMPs), and galectin-3 expression., Results: HFD presented larger adipocytes (p < 0.05), and lower vascular density and MMP-9 activity (p < 0.01) than C, while a major number of smaller adipocytes (p < 0.05) and an increase in vascularity (p < 0.001) and MMP-9 activity (p < 0.01) was observed in HFD + LGT. Collagen content was higher (p < 0.05) in EAT from HFD and decreased in HFD + LGT. In C, C + LGT, and HFD + LGT, mitochondria were predominantly tubular-shaped while in HFD mitochondria were mostly spherical (p < 0.001)., Conclusion: LGT positively influences VAT behavior by modulating gelatinase activity, enhancing vascularization, and improving adipocyte histological characteristics. Additionally, LGT improves mitochondrial dynamics, a process that would favor VAT functionality., Competing Interests: The authors declare no competing interests., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
13. Oxalate nephropathy in association with gastric bypass.
- Author
-
González Mintrone T, Castro F, Abuchanab M, De Rosa M, Toniolo MF, Carrozza D, and Finocchietto P
- Subjects
- Humans, Female, Middle Aged, Acute Kidney Injury etiology, Oxalates adverse effects, Obesity, Morbid surgery, Gastric Bypass adverse effects, Hyperoxaluria etiology
- Abstract
We present the case of a 46-year-old woman with a history of Roux-en-Y gastric bypass one year prior, who presented to the emergency room with vomiting and oliguria lasting 10 days. Initial evaluation revealed acute kidney injury with serum creatinine 14.9 mg/dL (normal range 0.5-0.9), serum urea 240 mg/dL (normal range 17-49), proteinuria 0.10 g/day and a glomerular filtration rate less than 10 ml/min per 1.73 m2. Urine sediment showed 15-20 leukocytes and 25 red blood cells per field, with no cylinders or crystals observed. A renal biopsy was performed, and pathology showed oxalate crystals in renal tubules and interstitial fibrosis, confirming the diagnosis of oxalate nephropathy. Despite the administration of intravenous sodium bicarbonate, red blood cell transfusions and high doses of loop diuretics, renal failure persisted, as evidenced by the presence of oliguria, serum creatinine 13.5 mg/dL, serum urea 220 mg/dL and serum phosphate 8 mg/dL (normal range 2.5-4.5), and hemodialysis therapy was initiated 3 days after admission to the hospital until the present time. Increased oxalate absorption secondary to fat malabsorption due to bypass gastric causes hyperoxaluria, crystal deposition and oxalate nephropathy. The aim of this report is to highlight the strong correlation between oxalate nephropathy and bariatric surgery, with their implications.
- Published
- 2024
14. Tibial brown tumor as a presentation of primary hyperparathyroidism
- Author
-
Rueda DA, Nazionale BA, Espinal Jimenez AM, Carrozza DA, Finocchietto P, and Di Fonzo H
- Subjects
- Humans, Retrospective Studies, Tibia, Hyperparathyroidism, Primary
- Abstract
Cystic fibrous osteitis is a complication of a very evolved hyperparathyroidism. Because the determination of calcium, parathyroid hormone and vitamin D have become routine studies, this bone complication is uncommon in western countries. However, it should be considered in the differential diagnosis of hypercalcemia and lytic bone lesions. The treatment is to suppress the excess parathyroid hormone by parathyroidectomy and osteosynthesis in pathological fracture. We present the case of a female patient with primary hyperparathyroidism and a brown tumor in the right tibia., (Universidad Nacional de Córdoba)
- Published
- 2021
- Full Text
- View/download PDF
15. [Analysis of the first 100 patients with COVID-19 admitted to internal medicine wards at the Hospital de Clínicas José de San Martin, Buenos Aires University].
- Author
-
Ludueña MG, Labato M, Chiaradia V, Yamuni J, Finocchietto P, and Pisarevsky AA
- Subjects
- Argentina, Hospitals, Humans, Retrospective Studies, SARS-CoV-2, Universities, COVID-19, Internal Medicine
- Abstract
This retrospective descriptive study analyzes the clinical and epidemiological characteristics, the disease evolution and its association with laboratory markers of poor prognosis of the first 100 patients with COVID-19 admitted to internal medicine wards at the Hospital de Clínicas José de San Martín, University of Buenos Aires. Thirty-one patients were nursing home residents, the most common clinical manifestations were fever, cough and odynophagia. Regarding comorbidities, obesity was the most frequent one and hypertension was the most prevalent in patients with pneumonia. The most important predictors of mortality were age and pneumonia. Patients older than 70 years had higher acute phase reactants showing an exaggerated inflammatory response. Mortality was high (13%), compared to most reports (5%), probably because of the advanced age of our population and the unfavorable clinical conditions they presented at admission.
- Published
- 2020
16. Angiotensin II stimulation promotes mitochondrial fusion as a novel mechanism involved in protein kinase compartmentalization and cholesterol transport in human adrenocortical cells.
- Author
-
Helfenberger KE, Castillo AF, Mele PG, Fiore A, Herrera L, Finocchietto P, Podestá EJ, and Poderoso C
- Subjects
- Adrenal Gland Neoplasms drug therapy, Adrenal Gland Neoplasms pathology, Adrenocortical Carcinoma drug therapy, Adrenocortical Carcinoma pathology, Biological Transport, GTP Phosphohydrolases genetics, GTP Phosphohydrolases metabolism, Humans, Mitochondrial Proteins genetics, Mitochondrial Proteins metabolism, Phosphorylation, Tumor Cells, Cultured, Adrenal Gland Neoplasms metabolism, Adrenocortical Carcinoma metabolism, Angiotensin II pharmacology, Cholesterol metabolism, Mitochondrial Dynamics drug effects, Protein Kinases metabolism, Vasoconstrictor Agents pharmacology
- Abstract
In steroid-producing cells, cholesterol transport from the outer to the inner mitochondrial membrane is the first and rate-limiting step for the synthesis of all steroid hormones. Cholesterol can be transported into mitochondria by specific mitochondrial protein carriers like the steroidogenic acute regulatory protein (StAR). StAR is phosphorylated by mitochondrial ERK in a cAMP-dependent transduction pathway to achieve maximal steroid production. Mitochondria are highly dynamic organelles that undergo replication, mitophagy and morphology changes, all processes allowed by mitochondrial fusion and fission, known as mitochondrial dynamics. Mitofusin (Mfn) 1 and 2 are GTPases involved in the regulation of fusion, while dynamin-related protein 1 (Drp1) is the major regulator of mitochondrial fission. Despite the role of mitochondrial dynamics in neurological and endocrine disorders, little is known about fusion/fission in steroidogenic tissues. In this context, the present work aimed to study the role of angiotensin II (Ang II) in protein subcellular compartmentalization, mitochondrial dynamics and the involvement of this process in the regulation of aldosterone synthesis. We demonstrate here that Ang II stimulation promoted the recruitment and activation of PKCε, ERK and its upstream kinase MEK to the mitochondria, all of them essential for steroid synthesis. Moreover, Ang II prompted a shift from punctate to tubular/elongated (fusion) mitochondrial shape, in line with the observation of hormone-dependent upregulation of Mfn2 levels. Concomitantly, mitochondrial Drp1 was diminished, driving mitochondria toward fusion. Moreover, Mfn2 expression is required for StAR, ERK and MEK mitochondrial localization and ultimately for aldosterone synthesis. Collectively, this study provides fresh insights into the importance of hormonal regulation in mitochondrial dynamics as a novel mechanism involved in aldosterone production., (Copyright © 2019 Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
17. Emphysematous cystitis in an 87 year old man.
- Author
-
Rueda DA, Yannone IJ, Carrozza DA, Finocchietto P, and Di Fonzo H
- Subjects
- Aged, 80 and over, Humans, Male, Tomography, X-Ray Computed, Cystitis diagnostic imaging, Emphysema diagnostic imaging
- Abstract
Emphysematous cystitis is a complicated form of urinary tract infection, characterized by the presence of air inside the wall and in the light of the bladder, affecting more diabetics, elderly and immunosuppressed. The microorganisms that most frequently cause this entity are Escherichia coli and Klebsiella pneumoniae. Its treatment is based on broad-spectrum antibiotics, bladder catheterization and partial or total cystectomy in severe cases.
- Published
- 2019
- Full Text
- View/download PDF
18. Fitz-Hugh-Curtis Syndrome Caused by Gonococcal Infection in a Patient with Systemic Lupus Erythematous: A Case Report and Literature Review.
- Author
-
Rueda DA, Aballay L, Orbea L, Carrozza DA, Finocchietto P, Hernandez SB, Volpacchio MM, and di Fonzo H
- Subjects
- Female, Humans, Young Adult, Chlamydia Infections microbiology, Gonorrhea diagnosis, Hepatitis microbiology, Lupus Erythematosus, Systemic complications, Pelvic Inflammatory Disease microbiology, Peritonitis microbiology
- Abstract
BACKGROUND Fitz-Hugh-Curtis (FHC) syndrome is a perihepatitis linked to inflammatory pelvic disease. It can be caused by Neisseria gonorrhoeae or Chlamydia trachomatis infections. FHC syndrome usually presents with pain in the right hypochondrium and fever, associated with symptoms and signs of pelvic infection in women. CASE REPORT We present the case of a 22-year-old woman with systemic lupus erythematous (SLE) who presented with polyarthritis, cutaneous lesions, and abdominal pain. The diagnosis of FHC syndrome was based on the findings of abdominal computerized tomography (CT) and the isolation of Neisseria gonorrhoeae (NG) in blood cultures. The association of arthritis and cutaneous lesions was diagnosed as a syndrome of arthritis-dermatitis, also caused by systemic NG infection. The patient had a favorable outcome with antibiotic treatment. CONCLUSIONS FHC syndrome should be considered in sexually active young patients, mainly women, with pelvic infection and perihepatitis. It may be caused by disseminated gonococcal infection. An important risk factor is the serum complement deficit, which may predispose to severe forms. Low serum complement level is a frequent manifestation of active SLE. CT images showing the typical findings of perihepatitis allow making the correct diagnosis.
- Published
- 2017
- Full Text
- View/download PDF
19. Takotsubo Myocardiopathy and Hyperthyroidism: A Case Report and Literature Review.
- Author
-
Rueda D, Aguirre R, Contardo D, Finocchietto P, Hernandez S, and di Fonzo H
- Subjects
- Adult, Graves Disease diagnosis, Humans, Male, Takotsubo Cardiomyopathy diagnosis, Takotsubo Cardiomyopathy psychology, Graves Disease complications, Takotsubo Cardiomyopathy complications
- Abstract
BACKGROUND Takotsubo cardiomyopathy (TM), also called stress myocardiopathy or transient left ventricular apical ballooning syndrome, is characterized by acute left ventricular dysfunction with reversible wall motion abnormalities. TM resembles acute coronary syndrome (ACS) in the absence of coronary artery disease (CAD). In several reports, TM has been described in association with hyperthyroidism, suggesting the potential role of thyrotoxicosis in the pathophysiology. CASE REPORT We present the case of a 34-year-old man with TM associated with hyperthyroidism caused by Graves' disease. In this case, TM was also preceded by an emotional trigger. The diagnosis of TM was based on clinical manifestations, electrocardiographic and echocardiographic abnormalities, and the absence of coronary artery disease (CAD) in the angiography. A diagnosis of hyperthyroidism was made based on hormonal and antibody measurements. The patient had a favorable outcome, and the cardiac and thyroid disorders resolved. CONCLUSIONS Our case illustrates that thyroid disease, mainly hyperthyroidism, should be considered in patients with TM with or without previous emotional triggers. As in our patient, the outcome in TM is usually favorable, with reversibility of cardiac abnormalities.
- Published
- 2017
- Full Text
- View/download PDF
20. Intravascular Large B Cell Lymphoma Presenting as Fever of Unknown Origin and Diagnosed by Random Skin Biopsies: A Case Report and Literature Review.
- Author
-
di Fonzo H, Contardo D, Carrozza D, Finocchietto P, Rojano Crisson A, Cabral C, and de Los Angeles Juarez M
- Subjects
- Aged, Biopsy, Fatal Outcome, Female, Humans, L-Lactate Dehydrogenase blood, Fever of Unknown Origin etiology, Lymphoma, Large B-Cell, Diffuse pathology, Skin pathology, Vascular Neoplasms pathology
- Abstract
BACKGROUND Intravascular lymphoma (IVL) is a rare lymphoproliferative disorder characterized by the proliferation of large B lymphoma cells within the lumen of small-caliber blood vessels. Clinical features are nonspecific, presenting as a systemic disease with fever and may be life-threatening. Antemortem diagnosis is difficult but may be made with biopsies of affected tissues or with random skin biopsies. CASE REPORT We report the case of a 66-year-old white woman presenting with fever of unknown origin (FUO) who developed neurologic, pulmonary, and hematologic manifestations. The diagnosis of intravascular large B cell lymphoma (IVLBCL) was made by random skin biopsies. She received treatment with steroids, rituximab, cyclophosphamide, vincristine, and doxorubicin (R-CHOP). Her disease evolution was unfavorable and she died after her first cycle of chemotherapy. CONCLUSIONS Our case illustrates that IVL can present as FUO and should be considered in the differential diagnosis of this syndrome, especially in patients with neurologic compromise and persistently elevated serum lactate dehydrogenase. In this case, the diagnosis was made with cutaneous biopsies of visibly unaffected skin. As in our patient, the course of IVL is usually fatal within a few months.
- Published
- 2017
- Full Text
- View/download PDF
21. Cardiac-specific overexpression of thioredoxin 1 attenuates mitochondrial and myocardial dysfunction in septic mice.
- Author
-
Sánchez-Villamil JP, D'Annunzio V, Finocchietto P, Holod S, Rebagliati I, Pérez H, Peralta JG, Gelpi RJ, Poderoso JJ, and Carreras MC
- Subjects
- Animals, Antioxidants metabolism, Male, Mice, Mice, Transgenic, Mitochondria metabolism, Mitochondria pathology, Mitochondrial Diseases genetics, Myocardium pathology, Real-Time Polymerase Chain Reaction, Gene Expression, Mitochondria genetics, Myocardium metabolism, Sepsis physiopathology, Thioredoxins genetics, Thioredoxins metabolism
- Abstract
Sepsis-induced myocardial dysfunction is associated with increased oxidative stress and mitochondrial dysfunction. Current evidence suggests a protective role of thioredoxin-1 (Trx1) in the pathogenesis of cardiovascular diseases. However, it is unknown yet a putative role of Trx1 in sepsis-induced myocardial dysfunction, in which oxidative stress is an underlying cause. Transgenic male mice with Trx1 cardiac-specific overexpression (Trx1-Tg) and its wild-type control (wt) were subjected to cecal ligation and puncture or sham surgery. After 6, 18, and 24h, cardiac contractility, antioxidant enzymes, protein oxidation, and mitochondrial function were evaluated. Trx1 overexpression improved the average life expectancy (Trx1-Tg: 36, wt: 28h; p=0.0204). Sepsis induced a decrease in left ventricular developed pressure in both groups, while the contractile reserve, estimated as the response to β-adrenergic stimulus, was higher in Trx1-Tg in relation to wt, after 6h of the procedure. Trx1 overexpression attenuated complex I inhibition, protein carbonylation, and loss of membrane potential, and preserved Mn superoxide dismutase activity at 24h. Ultrastructural alterations in mitochondrial cristae were accompanied by reduced optic atrophy 1 (OPA1) fusion protein, and activation of dynamin-related protein 1 (Drp1) (fission protein) in wt mice at 24h, suggesting mitochondrial fusion/fission imbalance. PGC-1α gene expression showed a 2.5-fold increase in Trx1-Tg at 24h, suggesting mitochondrial biogenesis induction. Autophagy, demonstrated by electron microscopy and increased LC3-II/LC3-I ratio, was observed earlier in Trx1-Tg. In conclusion, Trx1 overexpression extends antioxidant protection, attenuates mitochondrial damage, and activates mitochondrial turnover (mitophagy and biogenesis), preserves contractile reserve and prolongs survival during sepsis., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
22. Control of muscle mitochondria by insulin entails activation of Akt2-mtNOS pathway: implications for the metabolic syndrome.
- Author
-
Finocchietto P, Barreyro F, Holod S, Peralta J, Franco MC, Méndez C, Converso DP, Estévez A, Carreras MC, and Poderoso JJ
- Subjects
- Enzyme Activation, Humans, Metabolic Syndrome enzymology, Mitochondria, Muscle enzymology, Muscle, Skeletal enzymology, Phosphatidylinositol 3-Kinases metabolism, Phosphorylation, Signal Transduction, Insulin physiology, Metabolic Syndrome metabolism, Mitochondria, Muscle physiology, Nitric Oxide Synthase metabolism, Proto-Oncogene Proteins c-akt metabolism
- Abstract
Background: In the metabolic syndrome with hyperinsulinemia, mitochondrial inhibition facilitates muscle fat and glycogen accumulation and accelerates its progression. In the last decade, nitric oxide (NO) emerged as a typical mitochondrial modulator by reversibly inhibiting citochrome oxidase and oxygen utilization. We wondered whether insulin-operated signaling pathways modulate mitochondrial respiration via NO, to alternatively release complete glucose oxidation to CO(2) and H(2)O or to drive glucose storage to glycogen., Methodology/principal Findings: We illustrate here that NO produced by translocated nNOS (mtNOS) is the insulin-signaling molecule that controls mitochondrial oxygen utilization. We evoke a hyperinsulinemic-normoglycemic non-invasive clamp by subcutaneously injecting adult male rats with long-lasting human insulin glargine that remains stable in plasma by several hours. At a precise concentration, insulin increased phospho-Akt2 that translocates to mitochondria and determines in situ phosphorylation and substantial cooperative mtNOS activation (+4-8 fold, P<.05), high NO, and a lowering of mitochondrial oxygen uptake and resting metabolic rate (-25 to -60%, P<.05). Comparing in vivo insulin metabolic effects on gastrocnemius muscles by direct electroporation of siRNA nNOS or empty vector in the two legs of the same animal, confirmed that in the silenced muscles disrupted mtNOS allows higher oxygen uptake and complete (U-(14)C)-glucose utilization respect to normal mtNOS in the vector-treated ones (respectively 37+/-3 vs 10+/-1 micromolO(2)/h.g tissue and 13+/-1 vs 7.2+/-1 micromol (3)H(2)O/h.g tissue, P<.05), which reciprocally restricted glycogen-synthesis by a half., Conclusions/significance: These evidences show that after energy replenishment, insulin depresses mitochondrial respiration in skeletal muscle via NO which permits substrates to be deposited as macromolecules; at discrete hyperinsulinemia, persistent mtNOS activation could contribute to mitochondrial dysfunction with insulin resistance and obesity and therefore, to the progression of the metabolic syndrome.
- Published
- 2008
- Full Text
- View/download PDF
23. Modulation of liver mitochondrial NOS is implicated in thyroid-dependent regulation of O(2) uptake.
- Author
-
Carreras MC, Peralta JG, Converso DP, Finocchietto PV, Rebagliati I, Zaninovich AA, and Poderoso JJ
- Subjects
- Animals, Arginine pharmacology, Electron Transport Complex IV metabolism, Hyperthyroidism metabolism, Hypothyroidism metabolism, Nitric Oxide Synthase Type II, Nitric Oxide Synthase Type III, Oxygen Consumption drug effects, Rats, Rats, Wistar, Liver enzymology, Mitochondria metabolism, Nitric Oxide Synthase metabolism, Oxygen Consumption physiology, Thyroxine pharmacology
- Abstract
Changes in O(2) uptake at different thyroid status have been explained on the basis of the modulation of mitochondrial enzymes and membrane biophysical properties. Regarding the nitric oxide (NO) effects, we tested whether liver mitochondrial nitric oxide synthase (mtNOS) participates in the modulation of O(2) uptake in thyroid disorders. Wistar rats were inoculated with 400 microCi (131)I (hypothyroid group), 20 microg thyroxine (T(4))/100 g body wt administered daily for 2 wk (hyperthyroid group) or vehicle (control). Basal metabolic rate, mitochondrial function, and mtNOS activity were analyzed. Systemic and liver mitochondrial O(2) uptake and cytochrome oxidase activity were lower in hypothyroid rats with respect to controls; mitochondrial parameters were further decreased by L-arginine (-42 and -34%, P < 0.05), consistent with 5- to 10-fold increases in matrix NO concentration. Accordingly, mtNOS expression (75%) and activity (260%) were selectively increased in hypothyroidism and reverted by hormone replacement without changes in other nitric oxide isoforms. Moreover, mtNOS activity correlated with serum 3,5,3'-triiodothyronine (T(3)) and O(2) uptake. Increased mtNOS activity was also observed in skeletal muscle mitochondria from hypothyroid rats. Therefore, we suggest that modulation of mtNOS is a substantial part of thyroid effects on mitochondrial O(2) uptake.
- Published
- 2001
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.